Abstract
The diagnostic assays currently used to detect Shigella spp. (Shigella) and enterotoxigenic Escherichia coli (ETEC) are complex or elaborate which make them difficult to apply in resource poor settings where these diseases are endemic. The simple and rapid nucleic acid amplification-based assay “Rapid LAMP-based Diagnostic Test (RLDT)” was evaluated to detect Shigella spp (Shigella) and enterotoxigenic Escherichia coli (ETEC) and determine the epidemiology of these pathogens in Kolkata, India. Stool samples (n = 405) from children under five years old with diarrhea seeking care at the hospitals were tested, and 85(21%) and 68(17%) by RLDT, 91(23%) and 58(14%) by quantitative PCR (qPCR) and 35(9%) and 15(4%) by culture, were positive for Shigella and ETEC, respectively. The RLDT showed almost perfect agreement with qPCR, Kappa 0.96 and 0.89; sensitivity 93% and 98%; specificity 100% and 97% for Shigella and ETEC, respectively. While RLDT detected 12% more Shigella and 13% more ETEC than culture, all culture positives for Shigella and ETEC except one each were also positive by the RLDT, sensitivity 97% and 93% respectively. RLDT is a simple, sensitive, and rapid assay that could be implemented with minimum training in the endemic regions to strengthen the disease surveillance system and rapid outbreak detection.
Keywords: ETEC, Shigella, diarrhea, diagnostics, RLDT, qPCR, culture
Introduction
Shigella spp. (Shigella) and enterotoxigenic Escherichia coli (ETEC) are the leading enteropathogens causing significant diarrheal morbidity and mortality in children less than 5 years of age in sub-Saharan Africa and South Asian regions and could cause adverse long-term consequences including childhood stunting1. Recent longitudinal studies have found that Shigella and ETEC are the most common organisms requiring targeted interventions2. In the global burden study, Shigella and ETEC together were responsible for more than 427,000 deaths which ranked second and fourth respectively regarding pathogen contributions to global diarrheal deaths1. Licensed vaccines are not yet available for either pathogen, but vaccine candidates are under development, with the most advanced candidates potentially approaching phase III efficacy testing within the next few years3.
The genus Shigella includes four species, namely, S. fiexneri, S. dysenteriae, S. boydii, and S. sonnei, and each of these species is further classified into 6, 15, 23, and 1 serogroup respectively, based on the ‘O’ antigen component of the lipopolysaccharide4, 5. Among the four species, currently, S. fiexneri and S. sonnei are the major pathogens frequently reported in low and middle-income countries1, 6. The severity of shigellosis is depended on the various virulence factors located in the chromosome or large virulent inv plasmids. The invasion plasmid antigen H (ipaH) gene is common in all the Shigella serogroups and serotypes and is present in multiple copies located on both the plasmid and the chromosome. The ipaH gene is responsible for the diffusion of Shigella in epithelial cells7. ETEC colonizes the surface of the small intestine using the colonization factor antigens and elaborate heat-labile toxins (LT) and/or heat-stable toxins (STh or STp) which leads to secretory diarrhea8,9.
While culture remained the gold standard for the detection of Shigella, PCR to detect the toxin genes from the E. coli isolates is the most frequently used technique to detect ETEC. Shigella culture includes multiple subcultures, biochemical and serological confirmation, time-consuming, laborious, and not sensitive10, 11. Molecular technologies, such as PCR and quantitative PCR (qPCR) assays performed from purified DNA while are highly sensitive, however, are often not available in the endemic regions because of the requirement of specialized laboratories, trained personnel, expensive reagents, and equipment, and the risk of contamination12, 13.
Chakraborty et al. have developed a molecular diagnostic assay, Rapid LAMP-based Diagnostic Test (RLDT), for the detection of ETEC and Shigella directly from stool specimens14. RLDT is a simple, rapid, sensitive, and low-cost, cold chain and mostly electricity-free nucleic acid amplification-based method.
In this study, we evaluated the performance of the RLDT compared to qPCR and culture methods using stool specimens collected from the children with diarrhea and determined the feasibility of implementation of the RLDT in an ETEC and Shigella endemic setting, in Kolkata, India. We also determined the age-specific prevalence, clinical severity, and seasonality of Shigella and ETEC diarrhea in the study area.
Results
Comparative analysis between RLDT, qPCR, and culture for detection of Shigella and ETEC.
Overall, 405 stool samples were tested by the RLDT, qPCR, and culture for Shigella and ETEC. RLDT was done directly from the stool using the RLDT kit while qPCR was done from the purified DNA from the stool.
Shigella
Out of 405 samples tested for Shigella, 22.5% (91 of 405) were positive by the qPCR, 21% (85 of 405) by the RLDT, and 8.6% (35 of 405) by the culture (Fig. 1a). The sensitivity and specificity of RLDT for Shigella compared to qPCR were 93.4% and 100% respectively and compared to culture were 97.1% and 86.2% respectively (Table 1 in the supplementary section).
To calculate the agreement between paired assays, Cohen’s Kappa statistics were used. For the detection of Shigella, qPCR vs RLDT showed almost perfect agreement (0.96) while culture vs RLDT showed moderate agreement (0.51) since culture is less sensitive (Fig. 1b).
Based on the Venn diagram tool (Fig. 1c) 34 samples were positive for Shigella by all the 3 assays, culture, qPCR, and RLDT. Six samples were only positive by the qPCR, of which five samples had a Cq value close to the threshold (Cq29 to 31). With changing the cut-off to Cq28 (CFU ~105CFU/gm of stool), the sensitivity of RLDT was increased to 98.8%. RLDT and qPCR detected 51 (13%) more samples that were negative by culture. All the culture positives were also positive by the RLDT except one sample. This sample was culture positive for S. Sonnei, but negative by RLDT and qPCR with the Cq cut-off used.
ETEC
Among the stool specimens tested for ETEC 16.8% (68 of 405) were positive by the RLDT, 14.4% (58 of 404) by qPCR, and only 3.7% (15 of 405) were positive by culture followed by conventional PCR of the E. coli isolates (Fig. 2a).
Overall, the sensitivity and specificity of RLDT in the detection of ETEC compared to qPCR were 98.3% and 96.3% respectively (Table 1 in the supplementary section). The sensitivity of the RLDT compared to qPCR was high for STp (100%), followed by LT (95.3%) and STh (91.7%). The specificity for STh was 100% followed by LT (98.3%) and STp (97.9%). The sensitivity and specificity of RLDT compared to culture were 93.3% and 86.2% respectively. Among the ETEC genes, LT showed the highest sensitivity, 100% followed by ST 91.7% compared to culture. The specificity was high for ST (91.6%) followed by LT (90.2%).
The agreement between paired assays, qPCR, and RLDT had almost perfect agreement (0.89) while culture vs RLDT resulted in less than moderate agreement (0.29) as the culture is less sensitive (Fig. 2b).
Based on the Venn diagram (Fig. 2c), 14 samples were positive by all three assays. The qPCR and RLDT detected 43 (11%) more ETEC positive samples than culture. RLDT detected 11 more samples than qPCR. Since these samples were not further tested by another assay of similar sensitivity, it was not possible to confirm if these were false or real positives.
Among the ETEC toxin genes, the positivity rates by RLDT were 11.6% for LT, 5.4% for STh, and 6.4% for the STp gene. Using qPCR, the positivity rates were 10.6% for LT, 5.9% for STh, and 4.4% for STp gene. Culture could detect LT in 2% (8) and ST in 3% (12) of the samples (Fig. 3a). Among ETEC, LT showed the highest sensitivity, 100% followed by ST 91.7% compared to culture. The specificity was high for ST (91.6%) followed by LT (90.2%) (Table 1 in the supplementary section). The overall performance of ETEC toxin genes, qPCR vs RLDT showed almost perfect agreement (0.81 to 0.95) while the agreement of culture vs RLDT remained low (0.27 to 0.36) (Fig. 3b).
Prevalence of Shigella and ETEC and clinical severity
The prevalence of Shigella and ETEC in the study population was analysed using the randomly selected stool samples only (n = 385). Using the RLDT, the prevalence of Shigella and ETEC was 19.7% (76 of 385) and 17.7% (68 of 385) respectively. Among the 385 children, 12.2% (47) was LT-ETEC, 11.4% (44) ST-ETEC and 6.0% (23) was LT + ST-ETEC (Fig. 4).
The older kids (2 to 5 years of age) compared to the infants (< 2 years) were more likely to develop severe clinical symptoms including vomiting [OR 1.93 (95% CI 1.11–3.45; p = 0.222)], abdominal pain [OR 3.89 (2.06–7.22; p < 0.001)] and dehydration, [OR 2.66 (1.54–4.57; p < 0.001)]. Any dehydration was observed in 21.6% (66 of 305) of the children of which 30.3% were ETEC and 69.7% were Shigella positives. Among the children with ETEC positive diarrhea with dehydration, 45% was LT-ETEC, 30% ST-ETEC, and 25% was LT + ST-ETEC. Diarrhea episodes were significantly associated with fever [OR 2.32 (1.44–3.74, p = 0.0005)] when Shigella was detected and associated with abdominal pain [OR 2.37 (1.16–4.61, p = 0.0136)] when ETEC was detected. Abdominal pain was significantly associated with LT + ST-ETEC infected patients [OR 4.07 (1.55–10, p = 0.014)] compared to children with non LT + ST-ETEC diarrhea.
The frequently prescribed antibiotics at the hospitals for the treatment of diarrhea were fluoroquinolone and metronidazole, along with probiotics. Antibiotic treatment was prescribed at the hospital to 8.2% (33 of 305) of the children with diarrhea in the study. The odds of receiving antibiotic treatment were higher if the diarrhea episode was associated with vomiting [OR 4.37 (1.79–13; p = 0.003] and abdominal pain [OR 17.4 (8.01–39; p < 0.001)]. The proportion of children who received antibiotics among the ETEC positives (7 of 58, 12.0%) and Shigella positives (11 of 91, 12.1%) was similar. Among ETEC and Shigella positive children, the odds of getting antibiotics were significantly higher if abdominal pain was present [OR 32.2 (4.69, 65) p < 0.002)] and [OR 9.47 (2.41–39) p < 0.001] respectively. Children with ST-ETEC diarrhea had a higher odds of receiving antibiotics [OR 3.31 (1.04, 8.97; p = 0.026)] compared to non ST-ETEC diarrhea.
The proportion of ETEC and Shigella was highest during the monsoon season (May–August) in all the years followed by post-monsoon seasons (October–December) and pre-monsoon (March–April). The isolation rate was relatively low during the winter season that is, during January and February (Indian Meteorological Department, 2022) (Fig. 1a in the supplementary material section). The prevalence of the types of ETEC toxins varied by season (Fig. 1b in the supplementary material section). LT-ETEC was higher in the fall and winter while LT + ST-ETEC was higher in the summer and monsoon.
Discussion
This study was the first field evaluation of RLDT for Shigella in an endemic country and the first evaluation of RLDT for ETEC in Asia. Here, we established that the performance of Shigella and ETEC RLDT are comparable to the quantitative PCR, with the sensitivity and specificity ranging from 93 to 100%, and excellent agreement between the two assays. While the RLDT assay was much more sensitive than the culture, almost all the culture positives were also positive by the RLDT. The RLDT could detect 12% more Shigella and 13% more ETEC compared to the respective cultures. The performance of the RLDT in India was comparable to the previous reports of the RLDT evaluation studies at JHU10 and in Zambia19.
Shigella and ETEC are important pathogens that are largely responsible for foodborne illnesses occurring around the world20, 21, particularly in low and middle-income countries4. Active and rapid monitoring through surveillance is thus essential for the control of these bacterial infections and outbreaks22. Our study showed that the RLDT is a simple and rapid gene amplification tool to detect ETEC and Shigella directly from the stool. Since the assay is simple and the hands on time is less than five minutes, this could be implemented at the study site in Kolkata, India, with minimal training. RLDT method is less time consuming than culture-based techniques, conventional PCR assays, and qPCR, and therefore, could be performed easily and rapidly by the staff at the study site.
ICMR-NICED under the Government of India, is one of the few institutes in India, where a surveillance system for enteric diseases had been established and performed routinely. Under this system, stool specimens are collected from acute diarrheal patients hospitalized at the ID and BCRM hospitals representing every fifth hospitalized case with diarrhea on two randomly selected days in a week. These specimens are then examined at the microbiology laboratories at the NICED for common enteric pathogens using the established methods. For Shigella, culture, and ETEC, culture followed by PCR of the E. coli isolates are used. The surveillance data are sent to the ICMR and the Ministry of Health, India. In the previously published reports from this surveillance system, Shigella was isolated at 7.9% (51/648) from < 5 years old children in 2007 to 200915 and 7.7% (193/2489) from all ages in 2001 to 200423. ETEC was isolated at 4.2% (27/648) from < 5 years in 2007 to 200915; from all age groups, 4.3% (164/3826) in 2008–201124, and 3.7% (329/8891) in 2012–201925.
While the isolation rates in this study by culture were similar to the previous reports by the ICMR-NICED, however, using qPCR and RLDT, the isolation rates were much higher, ~ 3 folds for Shigella and ~ 4 folds for ETEC compared to culture. Therefore, the culture method largely underestimates the actual burden of these pathogens. Understanding the real burden of these significant pathogens at the national and sub-national levels is critical to guide global and local public health officials and policymakers to prioritize resources for accelerating vaccine development and implementation and other interventions to control these enteric infections. To strengthen surveillance of enteric diseases like Shigella and ETEC and rapid reporting at the national level to estimate disease prevalence and rapid response to contain outbreaks, a rapid, simple, as well as sensitive tool like the RLDT would be useful. In addition, rapid and simple detection of ETEC and Shigella using RLDT could guide the treatment decisions with antibiotics for these pathogens which could reduce the overuse of antibiotics at the health care facilities.
Since RLDT can be easily implemented in the endemic countries, it could be a useful screening tool in the Shigella and ETEC vaccine candidate evaluations in the upcoming phase III trials. Since the assay is rapid, the samples positive by the RLDT could be cultured and isolated colonies tested for antimicrobial resistance and whole genome sequencing.
In this study, we found that Shigella and ETEC are highly prevalent in Kolkata, India, causing moderate to severe diarrhea in under 5 years old children, which requires hospital visits. Therefore, there is an urgent need to control these diarrheal diseases to reduce mortality and short- and long-term morbidity among children.
This study has limitations. We used a stringent cutoff of ~ 104 CFU/gm of stool for Shigella, which reduced the sensitivity of the RLDT compared to qPCR, which was increased when the cutoff was increased. In addition, the sample preparation methods for RLDT, qPCR, and culture were different. RLDT was done directly from the stool with minimum sample treatment; qPCR was done from purified DNA; isolates from culture were tested with biochemical test and serogrouping for Shigella and PCR for ETEC. Therefore, the sensitivity of these assays depends not only on the amplification technology but also on the starting material.
In conclusion, the results of our study demonstrated that the RLDT assay is a sensitive molecular test for rapid and reliable identification of Shigella and ETEC infections from the stool. This study also showed that the RLDT could be easily implemented in an endemic setting like Kolkata, and the assay is much simple and rapid compared to qPCR, PCR, and culture methods. The RLDT is a simple and practical tool for the detection of Shigella and ETEC, which has the potential to be used for disease surveillance, outbreak detection, and vaccine evaluation in phase III trials and for on-site patient diagnosis for treatment.
Methods
Study design
Training of the RLDT assay: A team from the Johns Hopkins University visited the Indian Council of Medical Research (ICMR) - National Institute of Cholera and Enteric Diseases (NICED), Kolkata, and performed training on the RLDT and the qPCR for ETEC and Shigella. For the RLDT training, a written protocol and a video of the procedures were provided to the NICED staff followed by hands-on training on the first day. The staff at the NICED then performed the RLDT assay under the observation of the JHU trainers for the next two days.
Sample collection and selection
In the systematic active surveillance at the NICED, stool specimens were collected from children with diarrhea, younger than 5 years of age who were treated at the Infectious Diseases (ID) Hospital or B. C. Roy Memorial (BCRM) Hospital for Children in Kolkata. Stool specimens were collected before any administration of antibiotics at the hospitals. Clinical symptoms e.g., loose/watery or bloody diarrhea, degree of dehydration (severe, some or no according to the WHO guideline), abdominal pain, vomiting, and fever were recorded. Stool specimens were collected in sterile McCartney bottles and transported from the study hospitals within 2 hrs to the microbiology laboratory of the NICED. Stool samples were tested for 24 enteric pathogens comprising bacterial, viral, and parasitic pathogens using a combination of conventional, immunological, and molecular methods at the NICED15 and an aliquot of the stool samples were stored at −80°C. The clinical, demographic, and laboratory data were checked manually and entered into pre-designed data entry software (Oracle, India).
The stool samples for this study were randomly selected from the stored samples at −80°C from 2011 to 2019 and from the freshly collected stool samples in 2020. To increase the number of Shigella positive samples, twenty additional stool samples which were bloody or mucoid, or both were added. The total sample size in this study was 405 (randomly selected 385 samples + 20 suspected Shigella cases).
Culture for Shigella and ETEC
Soon after collection, the fresh stool specimens were cultured for Shigella and ETEC, and serogroups of Shigella were identified. For detection of Shigella, stool samples were cultured on Hekton Enteric agar (HEA agar) and Xylose Lysine Deoxycholate agar (XLD agar) (DB, Difco, Sparks, MD, USA, followed by biochemical tests and serotyped using commercially available antisera (Denka Seiken, Tokyo, Japan). For detection of ETEC, stool samples were cultured on MacConkey agar (BB, Difco, Sparks, MD, USA) and three isolated E. coli-like lactose-fermenting colonies were tested using multiplex conventional PCR assay for the detection of LT and ST toxin genes16. This PCR used common primer pairs for ST which was not distinguished by STh and STp.
Quantitative PCR and RLDT assay
DNA was extracted from 200 mg (200 μl) of stool using a bead beater followed by QIAmp Stool Mini Kit (Qiagen, Valencia, CA, USA)10. The concentrations of DNA were determined by measuring the optical density at 260 nm with a Nano Drop Bio Spectrometer (Eppendorf, Hamburg, Germany). The qPCR was performed with the isolated DNA to detect the target genes LT, STh, and STp for ETEC and ipaH for Shigella. The qPCR assay was performed using an SYBR Green master mix (Roche Diagnostics) and was carried out in a 25 μL reaction mixtures containing 1X PowerUp SYBR Green Master Mix, 0.2 μM of each primer and 2.5 μL of sample DNA and ampli ed for 40 cycles of 95°C for 15s and 60°C for 1 min using a Roche Light-Cycler 480 (Roche Diagnostics, Penzberg, Germany)10. ETEC strain H10407 and S. fiexneri 2a 2457T were used as positive controls.
RLDT
RLDT was conducted at the NICED directly from the stool samples using the RLDT kits to detect LT, STh, and STp genes for ETEC and ipaH for Shigella as described by Chakraborty et al14. In short, samples were added to the sample processing tube with lysis buffer followed by heat lysis. The processed samples were then added to the lyophilized ETEC and Shigella RLDT reaction strips. Each strip consisted of 8 tubes, organized as two reaction tubes each for LT, STh, and ipaH and one tube for STp. One reaction tube was added as the RLDT inhibitor control14. The strips were run for 40 minutes in the handheld, battery-operated, RLDT real-time uorometer reader (Agdia Inc, IN, USA)14.
Data analysis:
To determine the sensitivity and specificity of the RLDT for ETEC and Shigella the results were compared between qPCR, RLDT, and culture. The qPCR and RLDT tests were run and interpreted by two lab personnel blinded to each other. “ETEC total” was considered positive when at least one of the ETEC genes, LT, STh, or STp was positive. The sensitivity and specificity values were expressed as percentages. For analysis, the cut-off value of qPCR to determine positives was assigned as the lowest detection limits (LOD) of the RLDT assays, 104 CFU/gm of stool (corresponds to qPCR Cq of 30.49) for Shigella and 105CFU/gm of stool for ETEC genes (corresponds to qPCR Cq of 28.2, 28.6 and 30.07 for LT, STh, and STp respectively)10. The agreement between two assays were detected using Cohen’s Kappa. Cohen’s kappa does not require the specification of a gold standard but simply quantifies the agreement between binary outcomes of tests (positive or negative), considering agreement occurring by chance17,18. The following labels were assigned to the corresponding ranges of kappa strength: poor agreement, < 0; slight, 0.0 to 0.20; fair, 0.21 to 0.40; moderate, 0.41 to 0.60; substantial, 0.61 to 0.80; and almost perfect, 0.81 to 1.00. The Statistical analyses were performed using Stata Corp LLS (Version 16) and GraphPad, CA (Version 9).
Acknowledgment.
We thank all the patients who contributed stool samples that were used in this study. The authors thank the staff of the NICED laboratory and the JHU laboratory for their support. ICMR-NICED thanks ICMR, New Delhi for the core support.
Funding
This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under the Award Number R21AI137804. This study was partially supported by the Indian Council of Medical Research (ICMR), Government of India, New Delhi, India. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Footnotes
Ethics statement
The study was reviewed and approved by the institutional Ethical Review Committee at the ICMR-NICED and the Institutional Review Board of the Johns Hopkins Bloomberg School of Public Health. Written informed consent was obtained from the parents / legal guardians of the children. All methods were performed in accordance with the relevant guidelines and regulations.
Disclosure
The authors report no conflicts of interest concerning this work.
Additional Declarations: No competing interests reported.
Supplementary Files
Contributor Information
Goutam Chowdhury, ICMR-National Institute of Cholera and Enteric Diseases.
Debjani Ghosh, ICMR-National Institute of Cholera and Enteric Diseases.
YiYi Zhou, Johns Hopkins Bloomberg School of Public Health.
Alok K. Deb, ICMR-National Institute of Cholera and Enteric Diseases
Asish Kumar Mukhopadhyay, ICMR-National Institute of Cholera and Enteric Diseases.
Shanta Dutta, ICMR-National Institute of Cholera and Enteric Diseases.
Subhra Chakraborty, Johns Hopkins Bloomberg School of Public Health.
Data availability
All data generated or analysed during this study are included in this manuscript and its Supplementary Information file.
References
- 1.Anderson J. D. et al. Burden of enterotoxigenic Escherichia coli and Shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis. The Lancet. Global health. 7(3), e321–e330 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kotloff K. L. et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (London, England). 382(9888), 209–222 (2013). [DOI] [PubMed] [Google Scholar]
- 3.Hosangadi D., Smith P. G., & Giersing B. K. Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. Vaccine. 37(50), 7372–7380 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.von Seidlein L. et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS medicine. 3(9), e353 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Livio S. et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 59(7), 933–941 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lindsay B. Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children. The American journal of tropical medicine and hygiene. 93(5), 918–924 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ashida H., & Sasakawa C. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria. Frontiers in cellular and infection microbiology. 5, 100 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Isidean S. D., Riddle M. S., Savarino S. J., & Porter C. K. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine. 29(37), 6167–6178 (2011). [DOI] [PubMed] [Google Scholar]
- 9.Kahali S. et al. Molecular epidemiology of diarrhoeagenic Escherichia coli associated with sporadic cases and outbreaks of diarrhoea between 2000 and 2001 in India. European journal of epidemiology. 19(5), 473–479 (2004). [DOI] [PubMed] [Google Scholar]
- 10.Connor S. et al. Evaluation of a simple, rapid and eld-adapted diagnostic assay for enterotoxigenic E. coli and Shigella. PLoS neglected tropical diseases. 16(2), e0010192 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lindsay B. et al. Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection. Journal of clinical microbiology. 51(10), 3263–3269 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Smith C. J., & Osborn A. M. Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology. FEMS microbiology ecology. 67(1), 6–20 (2009). [DOI] [PubMed] [Google Scholar]
- 13.Kralik P., & Ricchi M. A Basic Guide to Real Time PCR in Microbial Diagnostics: De nitions, Parameters, and Everything. Frontiers in microbiology. 8, 108 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chakraborty S., Connor S., & Velagic M. Development of a simple, rapid, and sensitive diagnostic assay for enterotoxigenic E. coli and Shigella spp applicable to endemic countries. PLoS neglected tropical diseases. 16(1), e0010180 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nair GB, Ramamurthy T, Bhattacharya MK, Krishnan T, Ganguly S, Saha DR, et al. Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India. Gut Pathog. 2010;2:4. 10.1186/1757-4749-2-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng B, Oundo J, et al. Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis. 2012;55:S294–302. 10.1093/cid/cis754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Landis JR, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977; 33:159–174. 10.2307/2529310 [DOI] [PubMed] [Google Scholar]
- 18.Feuerman M, Miller A. Relationships between statistical measures of agreement: sensitivity, speci city, and kappa. J. Eval. Clin. Pract 2008;14:930–933. 10.1111/j.1365-2753.2008.00984.x [DOI] [PubMed] [Google Scholar]
- 19.Silwamba S, Chilyabanyama ON, Liswaniso F, Chisenga CC, Chilengi R, Dougan G, et al. Field evaluation of a novel, rapid diagnostic assay, and molecular epidemiology of enterotoxigenic E. coli among Zambian children presenting with diarrhea. PLoS Negl Trop Dis. 2022;16:e0010207. https://doi: 10.1371/journal.pntd.0010207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Khalil I, Troeger CE, Blacker BF, Reiner RC Jr. Capturing the true burden of Shigella and ETEC: The way forward. Vaccine. 2019;37:4784–4786. https://doi: 10.1016/j.vaccine.2019.01.031. [DOI] [PubMed] [Google Scholar]
- 21.Hosangadi D, Smith PG, Kaslow DC, Giersing BK; WHO ETEC & Shigella Vaccine Consultation Expert Group. WHO consultation on ETEC and Shigella burden of disease, Geneva, 6–7th April 2017: Meeting report. Vaccine. 2019;37:7381–7390. https://doi: 10.1016/j.vaccine.2017.10.011 [DOI] [PubMed] [Google Scholar]
- 22.Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388:1291–301. https://doi: 10.1016/S0140-6736(16)31529-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect. 2005;133:1089–95. https://doi: 10.1017/S0950268805004498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dutta S, Guin S, Ghosh S, Pazhani GP, Rajendran K, Bhattacharya MK, et al. Trends in the prevalence of diarrheagenic Escherichia coli among hospitalized diarrheal patients in Kolkata, India. PLoS One. 2013;8:e56068. https://doi: 10.1371/journal.pone.0056068 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ghosh D, Chowdhury G, Samanta P, Shaw S, Deb AK, Bardhan M, et al. Characterization of diarrhoeagenic Escherichia coli with special reference to antimicrobial resistance isolated from hospitalized diarrhoeal patients in Kolkata (2012–2019), India. J Appl Microbiol. 2022;132:4544–4554. https://doi: 10.1111/jam.15548. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analysed during this study are included in this manuscript and its Supplementary Information file.